Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests.

Insulin secretion and glucose disappearance rate were measured in 66 subjects with a wide range of fasting plasma glucose levels. The acute insulin response was present in subjects with fasting glucose levels below 115 mg/dl but was absent above this level. The glucose disappearance rate related to the relative acute insulin response in subjects with fasting glucose below 115 mg/dl and to total insulin response when fasting glucose levels were above 115 mg/dl. A calculated glucose disappearance rate of 1.06 per cent per minute was found when the acute isulin response was zero. All subjects with fasting glucose levels greater than 115 mg/dl had glucose disappearance rates greater than 1.06. These studies support 1) epidemiological data indicating 115 mg/dl as an upper limit of normal for fasting plasma glucose levels and 1.0 per cent per minute as a lower limit of normal for the glucose disappearance rate, and 2) evidence for an important role for the acute insulin response in the determination of glucose disappearance rates during intravenous glucose tolerance tests.

[1]  R. Landgraf,et al.  Glucoreceptor Mechanisms in Islets of Langerhans , 1972, Diabetes.

[2]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[3]  E. Cerasi,et al.  Pathogenesis of diabetes in man. , 1972, Israel journal of medical sciences.

[4]  R Luft,et al.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. , 1967, Acta endocrinologica.

[5]  D. Porte,et al.  Relationships Between Intravenous Glucose Loads, Insulin Responses and Glucose Disappearance Rate1 , 1971 .

[6]  R. Gleason,et al.  Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose. , 1968, The Journal of clinical investigation.

[7]  D. Porte,et al.  The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. , 1967, The Journal of clinical investigation.

[8]  D. Kipnis,et al.  Plasma Insulin Responses to Glucose and Tolbutamide of Normal Weight and Obese Diabetic and Nondiabetic Subjects , 1966, Diabetes.

[9]  D. Porte,et al.  Insulin responses to glucose: evidence for a two pool system in man. , 1969, The Journal of clinical investigation.

[10]  D. Porte,et al.  Human insulin secretion: as integrated approach. , 1970, Annual review of medicine.

[11]  D. Porte,et al.  The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. , 1973, The Journal of clinical investigation.

[12]  E. Whorton,et al.  The prevalence of hyperlipidemia in a natural community. , 1973, Journal of chronic diseases.

[13]  G. Grodsky,et al.  Early Phase of Insulin Release , 1968, Diabetes.

[14]  M. Hulse,et al.  Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect. , 1973, Metabolism: clinical and experimental.

[15]  K. Johansen.  Mild diabetes in young subjects. Clinical aspects and plasma insulin response pattern. , 2009, Acta medica Scandinavica.

[16]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[17]  P. J. Randle,et al.  Insulin Secretion Mechanisms and Glucose Metabolism in Isolated Islets , 1972, Diabetes.

[18]  M. T. Brennan,et al.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. , 1967, The Journal of clinical investigation.

[19]  E. Cerasi,et al.  Quantitative Study on the Potentiating Effect of Arginine on Glucose-induced Insulin Response in Healthy, Prediabetic, and Diabetic Subjects , 1974, Diabetes.

[20]  W. Hazzard,et al.  Insulin Response to Glucagon: The Opposing Effects of Diabetes and Obesity , 1969, Diabetes.

[21]  G. Grodsky,et al.  Dynamics of insulin secretion by the perfused rat pancreas. , 1968, Endocrinology.

[22]  T. Deckert,et al.  Increase of Insulin Concentration in Maturity-Onset Diabetics by Phentolamine (Regitine®) Infusion , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[23]  H. Keen,et al.  Oral Glucose Tolerance and Related Factors in a Normal Population Sample—I. Blood Sugar, Plasma Insulin, Glyceride, and Cholesterol Measurements and the Effects of Age and Sex , 1969, British medical journal.

[24]  G. Reaven,et al.  Relationship Between Insulin Response During the Intravenous Glucose Tolerance Test, Rate of Fractional Glucose Removal and the Degree of Insulin Resistance in Normal Adults , 1974, Diabetes.

[25]  E. Cerasi,et al.  Decreased Sensitivity of the Pancreatic Beta Cells to Glucose in Prediabetic and Diabetic Subjects: A Glucose Dose-Response Study , 1972, Diabetes.

[26]  A. Vinik,et al.  Selective Loss of Beta Cell Response to Glucose in Chronic Pancreatitis , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[27]  D. Porte,et al.  Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects. , 1971, Metabolism: clinical and experimental.

[28]  E. Cerasi,et al.  Insulin response to glucose infusion during pregnancy. A prospective study of high and low insulin responders with normal carbohydrate tolerance. , 1974, Acta endocrinologica.

[29]  D. Porte,et al.  Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. , 1972, The Journal of clinical investigation.